These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

149 related items for PubMed ID: 9047247

  • 21. Increased tumor uptake of chemotherapeutics and improved chemoresponse by novel non-anticoagulant low molecular weight heparin.
    Phillips PG, Yalcin M, Cui H, Abdel-Nabi H, Sajjad M, Bernacki R, Veith J, Mousa SA.
    Anticancer Res; 2011 Feb; 31(2):411-9. PubMed ID: 21378319
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Antiangiogenic and antitumor effects of a protein kinase Cbeta inhibitor in human breast cancer and ovarian cancer xenografts.
    Teicher BA, Menon K, Alvarez E, Shih C, Faul MM.
    Invest New Drugs; 2002 Aug; 20(3):241-51. PubMed ID: 12201487
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. A novel taxane with improved tolerability and therapeutic activity in a panel of human tumor xenografts.
    Polizzi D, Pratesi G, Tortoreto M, Supino R, Riva A, Bombardelli E, Zunino F.
    Cancer Res; 1999 Mar 01; 59(5):1036-40. PubMed ID: 10070960
    [Abstract] [Full Text] [Related]

  • 27. Reversal of multidrug resistance by two nordihydroguaiaretic acid derivatives, M4N and maltose-M3N, and their use in combination with doxorubicin or paclitaxel.
    Chang CC, Liang YC, Klutz A, Hsu CI, Lin CF, Mold DE, Chou TC, Lee YC, Huang RC.
    Cancer Chemother Pharmacol; 2006 Nov 01; 58(5):640-53. PubMed ID: 16544145
    [Abstract] [Full Text] [Related]

  • 28. cDNA microarray analysis of isogenic paclitaxel- and doxorubicin-resistant breast tumor cell lines reveals distinct drug-specific genetic signatures of resistance.
    Villeneuve DJ, Hembruff SL, Veitch Z, Cecchetto M, Dew WA, Parissenti AM.
    Breast Cancer Res Treat; 2006 Mar 01; 96(1):17-39. PubMed ID: 16322897
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Potentiation of antitumor activity of mitomycin C by estradiol: studies of human breast carcinoma xenografts serially transplanted into nude mice.
    Oka S, Kubota T, Takeuchi T, Kitajima M.
    J Surg Oncol; 1996 Apr 01; 61(4):256-61. PubMed ID: 8627994
    [Abstract] [Full Text] [Related]

  • 34. Effect of Paclitaxel on Antitumor Activity of Cyclophosphamide: Study on Two Transplanted Tumors in Mice.
    Kaledin VI, Nikolin VP, Popova NA, Pyshnaya IA, Bogdanova LA, Morozkova TS.
    Bull Exp Biol Med; 2015 Nov 01; 160(1):81-3. PubMed ID: 26597686
    [Abstract] [Full Text] [Related]

  • 35. Pharmacokinetics, tissue distribution and anti-tumour efficacy of paclitaxel delivered by polyvinylpyrrolidone solid dispersion.
    Liu X, Sun J, Chen X, Wang S, Scott H, Zhang X, Zhang Q.
    J Pharm Pharmacol; 2012 Jun 01; 64(6):775-82. PubMed ID: 22571255
    [Abstract] [Full Text] [Related]

  • 36. Antitumor activity of hydrophilic Paclitaxel copolymer prodrug using locoregional delivery in human orthotopic non-small cell lung cancer xenograft models.
    Zou Y, Fu H, Ghosh S, Farquhar D, Klostergaard J.
    Clin Cancer Res; 2004 Nov 01; 10(21):7382-91. PubMed ID: 15534115
    [Abstract] [Full Text] [Related]

  • 37. Apoptosis susceptibility of human carcinoma and leukemia cell lines to taxol. Relationship with cell cycle and drug concentration.
    Gangemi RM, Costa G, Fulco RA, d'Aquino S, Aronadio O.
    Ann N Y Acad Sci; 1996 Apr 30; 784():550-4. PubMed ID: 8651615
    [No Abstract] [Full Text] [Related]

  • 38. A novel triterpenoid isolated from the root bark of Ailanthus excelsa Roxb (Tree of Heaven), AECHL-1 as a potential anti-cancer agent.
    Lavhale MS, Kumar S, Mishra SH, Sitasawad SL.
    PLoS One; 2009 Apr 30; 4(4):e5365. PubMed ID: 19399188
    [Abstract] [Full Text] [Related]

  • 39. Differential activity of Cremophor EL and paclitaxel in patients' tumor cells and human carcinoma cell lines in vitro.
    Csóka K, Dhar S, Fridborg H, Larsson R, Nygren P.
    Cancer; 1997 Mar 15; 79(6):1225-33. PubMed ID: 9070502
    [Abstract] [Full Text] [Related]

  • 40. [Enhancement of antitumor activity of mitomycin C against human breast carcinoma xenografts by pretreatment with KM 2210].
    Yamamoto T, Kubota T, Oka S, Josui K, Fujita S, Arisawa Y, Suto A, Inoue S, Kuzuoka M, Ishibiki K.
    Gan To Kagaku Ryoho; 1990 Jan 15; 17(1):109-14. PubMed ID: 2105084
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.